Hemotune AG
The company develops a magnetic nanoparticle platform for targeted separation in medical and industrial applications. Its HemoSystem uses nanoengineered HemoBeads to remove specific disease triggers and antibodies directly from the bloodstream to treat conditions like sepsis and support gene therapy. The technology is also applied to bioprocessing and high-value industrial separation challenges.
Visit websiteSchlieren, Switzerland
Healthtech
Biotechnology
Nanotechnology
Medical Devices
Funding summary
- Total raised
- €7.1M
- Funding rounds
- 1
Investors in Hemotune AG
Investors on record for Hemotune AG. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Hemotune AG?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors